Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations
Authors:
- H. MössingerHMH. Mössinger
- M. SpannaglMSM. Spannagl
- M. JochumMJM. Jochum
- P. WendtPWP. Wendt
- A. BarankayABA. Barankay
- H. MeisnerHMH. Meisner
- J.A. RichterJRJ.A. Richter
- 1 April 1993
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 105 (4) , 712-720
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- In ReplyAnesthesiology, 1991
- Maternal-fetal transport of vitamin K1 and its effects on coagulation in premature infantsThe Journal of Pediatrics, 1989
- High-Dose Aprotinin: Hemostatic Effects in Open Heart OperationsThe Annals of Thoracic Surgery, 1989
- Pharmacology of Aprotinin and Efficacy During Cardiopulmonary BypassCardiovascular Drug Reviews, 1989
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION IN PATIENTS WITH SEPTIC ENDOCARDITIS HAVING OPEN-HEART SURGERYThe Lancet, 1988
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- Bleeding after Cardiopulmonary BypassNew England Journal of Medicine, 1986
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Factors XI and XII and Prekallikrein in Sick and Healthy Premature InfantsNew England Journal of Medicine, 1981
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981